ENGR. S. A. TO ENGR. H. B. NO. 2787 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
ENGROSSED SENATE AMENDMENT
TO
ENGROSSED HOUSE
BILL NO. 2787 By: Stinson of the House
and
Rogers of the Senate
[ stem cell research - information collection and
reporting duties of the State Department of Health
- effective date ]
AMENDMENT NO. 1. Page 1, strike the stricken title, enacting clause
and entire bill and insert
“An Act relating to public health; amending 63 O.S.
2021, Section 1-270.2, which relates to stem cell
research; modifying time period of certain report;
and providing an effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 1-270.2, is
amended to read as follows:
Section 1-270.2 A. For the purposes of the Advan cement in Stem
Cell Cures and Therapies Act, “human embryo” means a living organism
of the species Homo sapiens at the earliest stage of devel opment,
including the single -cell stage, that is not located in the body of
a woman.
ENGR. S. A. TO ENGR. H. B. NO. 2787 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. Research on human tissue regeneration and human diseases
using adult stem cells an d stem cells obtained from umbilical cord
blood and amniotic fluid may be conducted i n this state, provided
that the research is performed:
1. Safely and ethically;
2. Only on embryonic stem cell l ines created prior to August 1,
2001, and in accordance w ith federal law as it existed on November
1, 2007; and
3. Without the use of a human embryo, including a human embryo
produced using cloning technology.
C. When research is performed in accordance with the
Advancement in Stem Cell Cures and Therapies Act , a person or
governmental body shall not:
1. Restrict public funds designated for t he stem cell research;
or
2. Obstruct or provide disincentives for the stem cell
research.
D. The State Department of Health shall establish a reporting
system that collects information regarding all activities carried
out in accordance with this section .
E. The Department shall submit a report with all information
collected pursuant to subsection D of t his section to the Governor,
the Speaker of the Oklahoma House of Representatives, and the
ENGR. S. A. TO ENGR. H. B. NO. 2787 Page 3 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
President Pro Tempore of the State Senate no later than Decemb er 31
of each year every fifth year.
SECTION 2. This act shall become effective Novemb er 1, 2023.”
Passed the Senate the 20th day of April, 2023.
Presiding Officer of the Senate
Passed the House of Representatives the ____ day of __________,
2023.
Presiding Officer of the House
of Representatives
ENGR. H. B. NO. 2787 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
ENGROSSED HOUSE
BILL NO. 2787 By: Stinson of the House
and
Rogers of the Senate
[ stem cell research - information collection and
reporting duties of the State Department of Health
- effective date ]
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 3. AMENDATORY 63 O.S. 2021, Section 1-270.2, is
amended to read as follows:
Section 1-270.2 A. For the purposes of the Advancement in Stem
Cell Cures and Therapies Act, "human embryo" means a living organism
of the species Homo sapiens at the earliest stage of development,
including the single-cell stage, that is not located in the body of
a woman.
B. Research on human tissue regeneration and human diseases
using adult stem cells and ste m cells obtained from umbilical cord
blood and amniotic fluid may be conducted in this state, provided
that the research is performed:
ENGR. H. B. NO. 2787 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1. Safely and ethica lly;
2. Only on embryonic stem cell lines created prior to August 1,
2001, and in accordance with f ederal law as it existed on November
1, 2007; and
3. Without the use of a human embryo, including a human embryo
produced using cloning technology.
C. When research is performed in accordance with the
Advancement in Stem Cell Cures and Therapies Act, a p erson or
governmental body shall not:
1. Restrict public funds de signated for the stem cell research;
or
2. Obstruct or provide disincentives for the stem cell
research.
D. The State Department of Health shall est ablish a reporting
system that collects information regarding all activities carried
out in accordance wit h this section.
E. The Department shall submit a r eport with all information
collected pursuant to subsection D of this section to the Governor,
the Speaker of the Oklahoma House of Represe ntatives, and the
President Pro Tempore of the State Senate no lat er than December 31
of each year.
SECTION 4. This act shall become effect ive November 1, 2023.
ENGR. H. B. NO. 2787 Page 3 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Passed the House of Representatives the 23rd day of March, 2023.
Presiding Officer of the House
of Representatives
Passed the Senate the ___ day of _________, 2023.
Presiding Officer of the Senate